File Download

There are no files associated with this item.

Supplementary

Conference Paper: Comparative antibody persistence after natural COVID-19 infection or a primary course of 2 doses of either mRNA or inactivated COVID-19 vaccines [Poster Presentation]

TitleComparative antibody persistence after natural COVID-19 infection or a primary course of 2 doses of either mRNA or inactivated COVID-19 vaccines [Poster Presentation]
Authors
Issue Date29-Sep-2022
Persistent Identifierhttp://hdl.handle.net/10722/337092

 

DC FieldValueLanguage
dc.contributor.authorNg, WK-
dc.contributor.authorGuo, YY-
dc.contributor.authorKwok, SK-
dc.contributor.authorMok, KK-
dc.contributor.authorSo, HC-
dc.contributor.authorPeiris, JSM-
dc.contributor.authorIp, DKM-
dc.date.accessioned2024-03-11T10:18:02Z-
dc.date.available2024-03-11T10:18:02Z-
dc.date.issued2022-09-29-
dc.identifier.urihttp://hdl.handle.net/10722/337092-
dc.languageeng-
dc.relation.ispartofOptions for the Control of Influenza XI (26/09/2022-29/09/2022, Belfast)-
dc.titleComparative antibody persistence after natural COVID-19 infection or a primary course of 2 doses of either mRNA or inactivated COVID-19 vaccines [Poster Presentation]-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats